What is Boston Scientific's expected EPS for Q2 2026?

Analysts expect Boston Scientific (BSX) to report consensus EPS of approximately $0.83 for Q2 2026. Estimates range from $0.81 to $0.84.

What revenue do analysts expect for Boston Scientific in Q2 2026?

The consensus revenue forecast for Boston Scientific (BSX) in Q2 2026 is approximately $5.37B. Forecasts range from $5.31B to $5.42B.

How many analysts cover Boston Scientific?

14 analysts contribute to the Boston Scientific (BSX) Q2 2026 consensus estimate.

Has Boston Scientific beaten earnings estimates recently?

Boston Scientific beat analyst EPS estimates in 1 of the last 1 quarter. Boston Scientific beat revenue estimates in 1 of 1. In the most recent quarter (Q4 2025), Boston Scientific EPS beat by 2.5% and revenue beat by 0.2%.

When does Boston Scientific report Q2 2026 earnings?

Boston Scientific (BSX) is expected to report Q2 2026 earnings on July 29, 2026 before market open.

BSX Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$0.83

Consensus revenue · Q2 2026

$5.4B

Analysts

Expected report

Jul 29, 2026

Before open

Upcoming earnings

Locks in 1 day 22 hours · BMO: Locks 8:00 PM ET previous day

Revenue$5.4B$5.3B – $5.4B

EPS$0.83$0.81 – $0.84

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 14 analysts.

Metric	Low	Consensus	High
Revenue	$5.3B	$5.4B	$5.4B
EPS	$0.81	$0.83	$0.84
EBITDA	$1.2B	$1.2B	$1.3B
EBIT	$800.9M	$805.4M	$821.8M
Net income	$1.2B	$1.2B	$1.3B

Revenue$5.4B
EPS$0.83
EBITDA$1.2B
EBIT$805.4M
Net income$1.2B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q4 2025	$5.3B	$5.3B	+0.2%	$0.80	$0.78	+2.5%

Q4 2025+0.2%+2.5%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Boston Scientific (BSX) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 5 analysts.

Low: $55.00
Consensus: $78.00
Median: $70.00
High: $120.00
Current: $44.25
Upside: +76.3%

Upside calculated vs most recent trading price of $44.25.

Analyst ratings

Consensus: Buy — based on 44 analyst ratings.

Strong Buy 1Buy 38Hold 5

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 16, 2026	Truist Securities	maintain	Buy	Buy
Jul 15, 2026	Mizuho	maintain	Outperform	Outperform
Jul 13, 2026	RBC Capital	maintain	Outperform	Outperform
Jul 8, 2026	Needham	maintain	Buy	Buy
Jul 6, 2026	Evercore ISI Group	maintain	Outperform	Outperform
Jun 25, 2026	Stifel	maintain	Buy	Buy
Jun 24, 2026	Jefferies	maintain	Buy	Buy
Jun 16, 2026	BTIG	maintain	Buy	Buy
Jun 4, 2026	Truist Securities	maintain	Buy	Buy
Jun 3, 2026	BTIG	maintain	Buy	Buy

Jul 16, 2026Truist SecuritiesBuy
Jul 15, 2026MizuhoOutperform
Jul 13, 2026RBC CapitalOutperform
Jul 8, 2026NeedhamBuy
Jul 6, 2026Evercore ISI GroupOutperform
Jun 25, 2026StifelBuy
Jun 24, 2026JefferiesBuy
Jun 16, 2026BTIGBuy
Jun 4, 2026Truist SecuritiesBuy
Jun 3, 2026BTIGBuy

Frequently asked questions

Boston Scientific (BSX) Key Financials

Charts, filings, and peer comparison for every metric

Trains Forecasting

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

BSX Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation